GlaxoSmithKline Pharmaceuticals informs about board meeting

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2016, to consider, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2016 and to recommend dividend, if any, on the equity shares of the Company.

The above information is a part of company’s filings submitted to BSE.